This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Amaker, R. D. Articles by Bhatia, J. Search for Related Content PubMed PubMed Citation Articles by Amaker, R. D. Articles by Bhatia, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 05 1996, 1139-1142, Vol 40, No. 5
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation

RD Amaker, JT DiPiro and J Bhatia
Department of Pediatrics, Medical College of Georgia, Augusta 30912, USA.

Extracorporeal membrane oxygenation (ECMO) is a widely used therapy for neonates with respiratory failure. Because of sepsis, many of these infants require antibiotics like vancomycin during ECMO treatment. ECMO transiently alters renal function and increases the circulating blood volume by 75%. Initial vancomycin pharmacokinetics were determined in 12 infants undergoing ECMO to determine an adequate drug administration regimen. Vancomycin dosage was based on current recommendations for weight and gestational age. Pharmacokinetic parameters were determined by fitting the data to a two compartment model. This study yielded a mean steady-state volume of distribution of 1.1 +/- 0.5 (range, 0.6 to 2.1) liters/kg and a mean vancomycin clearance of 0.78 +/- 0.19 (range, 0.49 to 1.07) ml/min/kg. The mean vancomycin half-life was 16.9 +/- 9.5 (range, 8.8 to 42.9) h. Nomogram-calculated creatinine clearance was a significant predictor of vancomycin terminal rate constant and clearance. These data suggest alterations in the pharmacokinetics of vancomycin in infants on ECMO. With the goal of achieving vancomycin concentrations in serum above the MIC for the offending pathogen while using the least amount of the drug necessary, new administration guidelines for term infants without renal impairment undergoing ECMO should be 20 mg of vancomycin per kg at an interval of 24 h. With significant renal impairment, the interval should be extended on the basis of concentrations in serum. In comparison with previously published data, the neonates undergoing ECMO in our study demonstrated a much larger volume of distribution, a lower clearance, and consequently a longer vancomycin half-life.

This article has been cited by other articles:

• Ahsman, M. J., Wildschut, E. D., Tibboel, D., Mathot, R. A. (2009). Microanalysis of {beta}-Lactam Antibiotics and Vancomycin in Plasma for Pharmacokinetic Studies in Neonates. Antimicrob. Agents Chemother. 53: 75-80 [Abstract] [Full Text]  
• Bhatt-Mehta, V., Annich, G. (2005). Sedative clearance during extracorporeal membrane oxygenation. Perfusion 20: 309-315 [Abstract]